No Data
Mino Biotech: Report for the third quarter of 2024
Minnong Biological (301156.SZ): The net income for the first three quarters was 31.6116 million yuan, a year-on-year decrease of 36.49%.
Gelonghui October 29th | Meinong Biology (301156.SZ) announced its third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 0.34 billion yuan, a decrease of 9.19% year-on-year; net income attributable to shareholders of the listed company was 31.6116 million yuan, a decrease of 36.49% year-on-year; net income after deducting non-recurring gains and losses was 27.6796 million yuan, a decrease of 37.10% year-on-year; basic earnings per share were 0.2190 yuan per share.
Meinong Biology (301156.SZ) released its performance for the first three quarters, with a net income of 31.6116 million yuan, a decrease of 36.49%.
Meinong Biology (301156.SZ) released its third quarter report for 2024, the company's revenue for the first three quarters was 3...
Meinong Biology (301156.SZ): Subsidiary plans to invest approximately 0.391 billion yuan in the construction of an annual output of 0.1 million tons of corn protein processing project.
Mei Nong Bio (301156.SZ) announced that in the previous announcement, the company plans to establish a wholly-owned subsidiary to invest in the construction of a "1...
Express News | Meinong Biological: Wholly-owned subsidiary signed an investment agreement with the Leling Economic Development Zone Management Committee, Shandong.
Express News | Meinong Biology has established a new company with a capital of 0.1 billion yuan, including the business of manufacturing biobased materials.
No Data
No Data